Dr. Martin Steinhart received his medical degree from the University of Vienna. He gained solid national and international experience in various pharmaceutical companies in the areas of medical affairs, clinical and regulatory operations as well as in safety and quality in Austria and CEE. He joined AOP Health in July 2019 as the Chief of Research & Development in charge of the organizational, structural, and strategic set-up of the R&D area. Martin is Co-CEO of AOP Orphan Pharmaceutical GmbH and responsible for Research & Development, Medical Affairs, Business Development, Technical Operations and the Program Management Office.
Dr. Martin Steinhart
Dr. Martin Steinhart, CEO, AOP Orphan Pharmaceuticals GmbH, medical doctor by education, brings expertise in research and development as well as strategic know-how of international medical affairs and developing new markets.
At AOP Health, we strive to develop and market innovative and effective therapies for patients with rare diseases and in critical care. Our daily motivation is to provide sustainable support to those who need it most - the patients!